Medication info

Jenin 150 mg (Ranitidine Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
Korea PMG Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Expired

MFDS item code 201400259 · Approved 2014.01.21

This product's status changed to Expired on 2024.01.21. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (e.g., ulcers and esophagitis), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome
Who takes it
Adults · Children
Adult dose
For ranitidine, administer 150 mg orally twice daily, in the morning and at bedtime. Gastric and duodenal ulcers: Administer 150 mg orally twice daily or 300 mg once daily at bedtime. A higher treatment rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same for combination therapy to prevent ulcers caused by administration of nonsteroidal anti-inflammatory drugs or the development of gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, or within 8 weeks for conditions caused by administration of nonsteroidal anti-inflammatory drugs, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. Gastroesophageal reflux disease: Administer 150 mg twice daily for 8 weeks or 300 mg once daily before bedtime. For patients with severe gastroesophageal reflux disease, the dose may be increased to 150 mg 4 times daily. Zollinger-Ellison syndrome: Initiate treatment with 150 mg 3 times daily and increase the dose as needed. For severe disease, up to 6 g per day may be administered as directed by a physician. For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injectable formulation. Once oral administration is possible, switch to oral administration and administer 150 mg twice daily. Pre-anesthetic medication (prevention of Mendelson syndrome): Administer 150 mg 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis: Administer 150 mg once daily at bedtime. For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug; therefore, readjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.
Child dose
For patients 8 〜 18 years of age, 150 mg per dose (2 mg per kg of body weight) may be administered up to twice daily. For patients 12 years of age and older, administer 75 mg orally twice daily (oral solution only).

Ingredients

Manufacturer
Korea PMG Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., ulcers and esophagitis), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • post-operative ulcers
  • gastric and duodenal ulcers due to NSAID administration
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
  • acute gastritis
View approved original text

This medication is effective for conditions such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also used to prevent Mendelson's syndrome before anesthesia, and for gastric and duodenal ulcers after surgery and due to NSAID administration. It aids in improving gastric mucosal lesions due to acute gastritis, chronic gastritis acute exacerbation, and upper gastrointestinal bleeding. It is also effective for alleviating hyperacidity, heartburn, and sour stomach symptoms. This medication is used to treat various gastric-related diseases and symptoms and to improve symptoms.

How to take

Adult dose

For ranitidine, administer 150 mg orally twice daily, in the morning and at bedtime. Gastric and duodenal ulcers: Administer 150 mg orally twice daily or 300 mg once daily at bedtime. A higher treatment rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same for combination therapy to prevent ulcers caused by administration of nonsteroidal anti-inflammatory drugs or the development of gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, or within 8 weeks for conditions caused by administration of nonsteroidal anti-inflammatory drugs, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. Gastroesophageal reflux disease: Administer 150 mg twice daily for 8 weeks or 300 mg once daily before bedtime. For patients with severe gastroesophageal reflux disease, the dose may be increased to 150 mg 4 times daily. Zollinger-Ellison syndrome: Initiate treatment with 150 mg 3 times daily and increase the dose as needed. For severe disease, up to 6 g per day may be administered as directed by a physician. For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injectable formulation. Once oral administration is possible, switch to oral administration and administer 150 mg twice daily. Pre-anesthetic medication (prevention of Mendelson syndrome): Administer 150 mg 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis: Administer 150 mg once daily at bedtime. For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug; therefore, readjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.

Child dose

For patients 8 〜 18 years of age, 150 mg per dose (2 mg per kg of body weight) may be administered up to twice daily. For patients 12 years of age and older, administer 75 mg orally twice daily (oral solution only).

Precautions

This medication should not be used in patients with a history of allergic reaction to any ingredient of this medication. It should also not be administered to patients with a history of acute porphyria as it may trigger acute porphyric attacks. Additionally, this medication contains lactose and should not be given to patients with genetic issues such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption. Patients with impaired kidney function may have elevated serum concentrations of this medication and should reduce the dose or increase the dosing interval; those with impaired liver function should also use this medication with caution. Patients with a history of drug allergies, the elderly, and those taking non-steroidal anti-inflammatory drugs should be administered this medication carefully. Especially, since it can mask symptoms of gastric cancer, it is essential for patients with gastric ulcers or middle-aged patients with changes in recent indigestion symptoms to verify that it is not a malignant disease before use. Patients with gastric and duodenal ulcers caused by Helicobacter pylori need eradication therapy. This medication may rarely cause severe allergic reactions such as anaphylaxis shock, so if abnormal symptoms occur during administration, treatment should be discontinued immediately. If hypersensitivity reactions occur such as hives, rash, bronchospasm, or hypotension, administration should be stopped. Various side effects like blood cell count decrease, liver dysfunction, cardiac rhythm abnormalities, digestive disturbances, and neurological symptoms are rarely reported, and if symptoms arise, consult with a healthcare professional promptly. During treatment, abnormalities should be checked through blood tests, liver function tests, and kidney function tests. The elderly and patients with chronic diseases may have increased risk of pneumonia, so caution is required. If dizziness or drowsiness occurs, avoid driving or operating dangerous machinery. This medication may affect the absorption or metabolism of other drugs; thus, inform healthcare professionals of any concurrently administered medications. Particularly, when combined with anticoagulants like warfarin, the risk of bleeding may increase, necessitating periodic testing. Women who are pregnant or may become pregnant, as well as nursing women, should use this medication with caution, and it should only be given when the benefits outweigh the risks. Safety in children has not been fully established, so caution is necessary. The elderly may require dose adjustments due to potential drug accumulation from decreased kidney function. This medication may yield false positive results in some tests when using test strip methods, so accurate testing methods should be employed. While special toxicity symptoms from overdose are rare, symptomatic treatment such as vomiting or gastric lavage may be needed, and in severe cases, hemodialysis may be beneficial. Store this medication out of reach of children and do not transfer to another container.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • agranulocytosis
  • elevated serum creatinine
Show 57 more
  • leukopenia
  • thrombocytopenia
  • bone marrow suppression
  • aplastic anemia
  • hypoplastic anemia
  • pure red cell aplasia
  • eosinophilia
  • generalized fatigue
  • weakness
  • subcutaneous hemorrhage
  • mucosal hemorrhage
  • fever
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • atrioventricular block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • convulsions
  • headache
  • heaviness in the head
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • altered consciousness
  • liver-type myoclonus
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • stomatitis
  • pruritus
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container that can block light, in a dry place at room temperature between 1°C and 30°C. Proper storage will help maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.